← Back to Search

Behavioral Intervention

eHaRT-A for Alcoholism (eHaRT-A Trial)

Seattle, WA
Phase 3
Recruiting
Led By Tessa Frohe, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Being at least 21 years of age
Be older than 18 years old
Must not have
Refusal or inability to consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1- or 3- month follow-up.
Awards & highlights
Pivotal Trial
No Placebo-Only Group

Summary

This trial aims to convert a successful in-person alcohol harm-reduction treatment into a digital version called eHaRT-A. The study will focus on individuals who have faced homelessness and have an alcohol use disorder

See full description
Who is the study for?
This trial is for English-speaking adults over 21 who are registered at Housing First sites, currently drink alcohol, and meet the criteria for an Alcohol Use Disorder (AUD) as per the Diagnostic and Statistical Manual of Mental Health Disorders.Check my eligibility
What is being tested?
The study is testing eHaRT-A, a digital version of a face-to-face harm-reduction treatment designed for people with AUD who have experienced homelessness. It aims to see if it's more effective than standard services in reducing alcohol-related harm.See study design
What are the potential side effects?
Since eHaRT-A is a digital platform rather than a medication or medical procedure, traditional side effects are not applicable. However, participants may experience emotional or psychological discomfort while engaging with the content.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 21 years old or older.
 show original

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot or do not want to give consent for treatment.
 show original

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1- or 3- month follow-up.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1- or 3- month follow-up. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in alcohol-related harm from baseline through 3-month follow-up as assessed by the SIP-2R.
Change in physical and mental-health related quality of life from baseline through 3-month follow-up as measured by the EQ-5D-5L
Change in typical and peak alcohol quantity consumed from baseline through 3-month follow-up as assessed by the AQUA.
+1 more
Secondary study objectives
Change in alcohol frequency from baseline through 3-month follow-up as assessed by the ASI.
Change in biochemical verification of EtG from baseline to 3-month follow-up.
Change in motivation/readiness/importance/confidence to engage in harm reduction from baseline through 3-month follow-up as assessed by the MTC.
Other study objectives
Acceptability of the eHaRT-A intervention as assessed by the AIM at posttest.
Change in acceptability, effectiveness, and likelihood to engage in eHaRT-A activities as assessed by Acceptability Rulers.
Change in eHaRT receipt/enactment outcomes from baseline to 1-month follow-up as assessed by the SHaRE form.
+2 more

Awards & Highlights

Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Housing First + eHaRT-AExperimental Treatment1 Intervention
HaRT-A comprises three concrete treatment components: 1) measurement and participant-led tracking of indicators of alcohol-related harm (e.g., number of drinks, blackouts), 2) elicitation of harm-reduction and health related quality of life (HRQoL) goals (e.g., drink slower, eat healthier, reconnect with family), and 3) discussion of safer-drinking strategies (e.g., taking B-complex vitamins, eating prior to or during alcohol use, avoiding mixing alcohol and other drugs). HaRT-A honors community representation within harm-reduction intervention development and acknowledges the larger forces (familial, community, geopolitical) at play in substance use, thus emphasizing the wisdom of the participant in defining their own pathway to recovery.
Group II: Housing First As UsualActive Control1 Intervention
Housing First as usual includes housing provision and management, fulfillment of basic needs (e.g., food, clothing), nursing/medical services and case management.

Find a Location

Closest Location:Downtown Emergency Service Center· Seattle, WA· 2011 miles

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,855 Previous Clinical Trials
2,022,443 Total Patients Enrolled
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
862 Previous Clinical Trials
1,090,779 Total Patients Enrolled
Tessa Frohe, PhDPrincipal InvestigatorUniversity of Washington
~107 spots leftby Jan 2027